Evaluation of the ALIBIRD mHealth Platform for Care of Patients With Lung Cancer: Prospective Pilot Study
JMIR Cancer · 2026
DOI: 10.2196/69525 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR Cancer, 2026. Verfasst von Jose M Iniesta-Chamorro und 17 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, S…. Hauptthemen laut MEDLINE: Lung Neoplasms, Telemedicine, Mobile Applications. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Mobile health (mHealth) represents a promising instrument for optimizing symptom management and important lifestyle strategies that enhance self-care and the quality of health care for patients with cancer. The ALIBIRD mHealth platform is a digital health solution specifically designed for the telemonitoring of oncology patients, fostering patient empowerment and supporting clinical decision-making.
Objective
The primary objective of this study was to evaluate the patient experience with the ALIBIRD platform. In addition, the study aimed to assess clinical outcomes, particularly in symptom management, nutritional status, and lifestyle, using patient-reported outcome measures (PROMs).
Methods
The evaluation was conducted over a 30-week period in patients with advanced lung cancer receiving active treatment. Outcome variables included usability, patient experience, symptom burden, lifestyle behaviors (diet, physical activity, and sleep), nutritional status, PROMs, and system-generated clinical alerts. Through the mobile app, patients reported symptoms and completed integrated REDCap (Research Electronic Data Capture) questionnaires assessing lifestyle behaviors and PROMs, while receiving personalized recommendations informed by nutrigenetic and gut microbiota assessments. Daily activity and sleep data were automatically captured using the Fitbit Inspire wearable. Clinicians remotely monitored patient data using a web-based dashboard and performed clinical actions when required, including phone calls, therapeutic adjustments, referrals, and appointment rescheduling. Statistical analysis included descriptive summaries and pre-post comparisons of clinical and patient-reported outcomes.
Results
Out of 20 patients recruited for the study, 14 completed the intervention. The System Usability Scale yielded a score of 90, indicating high usability. Among the 14 completers, adherence to scheduled questionnaires ranged from 94% to 100% for several instruments, and wearable-based monitoring ranged from 66% to 96% across visits. Overall, the ALIBIRD platform collected and processed 3589 patient-reported outcomes related to physical activity, 3468 related to sleep, 679 on-demand symptom entries, and 1524 completed questionnaires. Clinically, 143 alerts were resolved within an average of 2.05 days, resulting in 2 referrals to emergency rooms and 2 early detections of disease progressions. Furthermore, more than 2100 personalized recommendations contributed to a 21% (3/14 patients) increase in adherence to the Mediterranean diet and a 14% (2/14 patients) increase in moderate physical activity.
Conclusions
The evaluation of the ALIBIRD implementation yielded promising results in that it facilitated the adoption of healthier lifestyle habits while enhancing health self-management among oncology patients. The ALIBIRD mHealth platform emerges as an effective digital health tool that enables closer monitoring of patients and thereby more informed clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.
- Instituto de Investigación Hospital 12 de Octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain.
- Clinical Oncology Group, IMDEA Nutrition, CEI UAM + CSIC, Madrid, Spain.
- Medical Oncology Department, Infanta Sofía University Hospital, Infanta Sofía and Henares Hospitals Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Paseo de Europa, 34, San Sebastián de los Reyes, Ma…
- GENYAL Platform, IMDEA Nutrition, CEI UAM + CSIC, Madrid, Spain.
- Institute of Food Science Research (CIAL), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid (UAM), Madrid, Spain.
ORCID-Profile: Jose M Iniesta-Chamorro, Maria Sereno, Beatriz Garrido-Rubiales, Marta Villarino Sanz, Isabel Espinosa-Salinas, Sandra Falagán Martínez, Gustavo Rubio Romero, Juan Moreno-Rubio, Beatriz Tabarés, Yolanda Martín, Irene Hernández de Córdoba, Maria Morales Parga, Natalia Molinero, M Victoria Moreno-Arribas, Guillermo Reglero Rada, Ana Ramírez de Molina, Enrique J Gómez, Enrique Casado
Zitieren
APA
Iniesta-Chamorro, J. M., Sereno, M., Garrido-Rubiales, B., Villarino Sanz, M., Espinosa-Salinas, I., Falagán Martínez, S., Rubio Romero, G., Moreno-Rubio, J., Tabarés, B., Martín, Y., Hernández de Córdoba, I., Morales Parga, M., Molinero, N., Moreno-Arribas, M. V., Reglero Rada, G., Ramírez de Molina, A., Gómez, E. J., & Casado, E. (2026). Evaluation of the ALIBIRD mHealth Platform for Care of Patients With Lung Cancer: Prospective Pilot Study. JMIR Cancer. https://doi.org/10.2196/69525
Vancouver
Iniesta-Chamorro JM, Sereno M, Garrido-Rubiales B, Villarino Sanz M, Espinosa-Salinas I, Falagán Martínez S, et al. Evaluation of the ALIBIRD mHealth Platform for Care of Patients With Lung Cancer: Prospective Pilot Study. JMIR Cancer. 2026. doi:10.2196/69525
BibTeX
@article{IniestaChamorro2026,
author = {Iniesta-Chamorro, Jose M and Sereno, Maria and Garrido-Rubiales, Beatriz and Villarino Sanz, Marta and Espinosa-Salinas, Isabel and Falagán Martínez, Sandra and Rubio Romero, Gustavo and Moreno-Rubio, Juan and Tabarés, Beatriz and Martín, Yolanda and Hernández de Córdoba, Irene and Morales Parga, Maria and Molinero, Natalia and Moreno-Arribas, M Victoria and Reglero Rada, Guillermo and Ramírez de Molina, Ana and Gómez, Enrique J and Casado, Enrique},
title = {Evaluation of the ALIBIRD mHealth Platform for Care of Patients With Lung Cancer: Prospective Pilot Study},
journal = {JMIR Cancer},
year = {2026},
doi = {10.2196/69525}
}
EUVIMED